1. Home
  2. HOWL vs LODE Comparison

HOWL vs LODE Comparison

Compare HOWL & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • LODE
  • Stock Information
  • Founded
  • HOWL 2017
  • LODE 2008
  • Country
  • HOWL United States
  • LODE United States
  • Employees
  • HOWL N/A
  • LODE N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • HOWL Health Care
  • LODE Industrials
  • Exchange
  • HOWL Nasdaq
  • LODE Nasdaq
  • Market Cap
  • HOWL 87.4M
  • LODE 79.6M
  • IPO Year
  • HOWL 2021
  • LODE N/A
  • Fundamental
  • Price
  • HOWL $1.49
  • LODE $0.35
  • Analyst Decision
  • HOWL Strong Buy
  • LODE Buy
  • Analyst Count
  • HOWL 2
  • LODE 1
  • Target Price
  • HOWL $9.50
  • LODE $2.60
  • AVG Volume (30 Days)
  • HOWL 260.9K
  • LODE 6.6M
  • Earning Date
  • HOWL 03-06-2025
  • LODE 02-26-2025
  • Dividend Yield
  • HOWL N/A
  • LODE N/A
  • EPS Growth
  • HOWL N/A
  • LODE N/A
  • EPS
  • HOWL N/A
  • LODE N/A
  • Revenue
  • HOWL $3,386,000.00
  • LODE $1,864,811.00
  • Revenue This Year
  • HOWL N/A
  • LODE $69.41
  • Revenue Next Year
  • HOWL $34.17
  • LODE $56.83
  • P/E Ratio
  • HOWL N/A
  • LODE N/A
  • Revenue Growth
  • HOWL N/A
  • LODE 117.46
  • 52 Week Low
  • HOWL $1.26
  • LODE $0.13
  • 52 Week High
  • HOWL $8.19
  • LODE $1.01
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 54.09
  • LODE 43.59
  • Support Level
  • HOWL $1.28
  • LODE $0.35
  • Resistance Level
  • HOWL $1.60
  • LODE $0.41
  • Average True Range (ATR)
  • HOWL 0.10
  • LODE 0.03
  • MACD
  • HOWL 0.03
  • LODE 0.00
  • Stochastic Oscillator
  • HOWL 67.65
  • LODE 23.89

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: